MayoCancerCare Profile Banner
Mayo Clinic Comprehensive Cancer Center Profile
Mayo Clinic Comprehensive Cancer Center

@MayoCancerCare

Followers
14K
Following
4K
Media
9K
Statuses
26K

Personalized #CancerTreatment + leading-edge #CancerResearch and #ClinicalTrials = unparalleled #CancerCare. https://t.co/g8MpWrFymC

Arizona, Florida and Minnesota
Joined March 2014
Don't wanna be here? Send us removal request.
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
5 days
When Dr. Bobby Mukkamala learned he had a brain tumor, he relied on the cutting-edge surgical techniques at Mayo Clinic to get him back to his professional work. Read his story:
Tweet media one
0
2
5
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
10 days
Cancer is a time-critical disease. Researchers built an AI model and examined our patient data to see if they could intercept cancers earlier than the time and date of the diagnosis. The model identified cancers up to 5 years earlier in 26% of patients.
Tweet card summary image
mayomagazine.mayoclinic.org
Building digital solutions to find cancer up to 5 years sooner.
0
0
1
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
10 days
Rates of stomach cancer among younger people (ages 20 to 40 years) are on the rise. Known as early-onset stomach cancer, it makes up around 30% of stomach cancer diagnoses. This is an alarming trend. Learn the signs and symptoms to catch it early.
Tweet card summary image
cancerblog.mayoclinic.org
Dr. Travis Grotz, a Mayo Clinic surgical oncologist, shares what people should know about the signs and symptoms of stomach cancer.
0
1
2
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
11 days
Dr. Bekaii-Saab is a medical oncologist and the Division Chair of Hematology and Oncology for the Cancer Center in Arizona. He hopes that his research will lead to better tools to tackle the highly complex and heterogeneous nature of gastrointestinal cancers. ⬇️.
@OncLive
OncLive.com
12 days
Tanios S. Bekaii-Saab, MD, (@GIcancerDoc) of @MayoCancerCare discusses sequencing approaches in metastatic pancreatic cancer and colorectal cancer. Read more here:
Tweet media one
0
0
3
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
17 days
News Alert! ⬇️.
@MayoClinic
Mayo Clinic
19 days
Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.⁠.⁠.Learn more:
Tweet media one
0
0
2
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
23 days
RT @MKD_BMT: Great lecture by Dr. James Foran from @MayoCancerCare in Jacksonville on updates in management of acute lymphoblastic leukemia….
0
6
0
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
25 days
Why it matters: Finding CHIP earlier could help guide proactive monitoring or preventive care. The tool is a path from genomic discovery to clinical decision-making.
newsnetwork.mayoclinic.org
Mayo Clinic AI tool finds early signs of blood mutations tied to heart disease and cancer 
0
0
1
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
25 days
How it works: The tool detects nearly 80% of CHIP mutations using whole-exome sequencing, which analyzes the protein-coding regions of DNA. CHIP makes leukemia more than 10 times more likely and raises the risk of heart disease up to four times, even in healthy adults.
1
0
0
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
25 days
Scientists have built a new AI tool that helps clinicians detect diseases like leukemia early. The tool showed promising results in a study co-led by Dr. Eric Klee: "Detecting disease at its earliest molecular roots is one of the most meaningful advances we can make in medicine.".
2
0
0
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
25 days
RT @MayoClinic: For the 36th consecutive year since U.S. News & World Report launched its "Best Hospitals" rankings, Mayo Clinic again rank….
0
74
0
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
CV Rao was diagnosed with a rare and aggressive cancer of the bile ducts. Surgery was the best treatment, but local surgeons said it wasn't possible. Learn how our second opinion gave him a chance to live to watch his sons grow and travel with his wife.
Tweet card summary image
newsnetwork.mayoclinic.org
Diagnosed with intrahepatic cholangiocarcinoma, a rare cancer of the bile ducts, he turned to Mayo Clinic when others could not help him.
1
0
2
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
Tomorrow's Cure podcast is available on Apple Podcast, Spotify, Pocketcast, Amazon Music, iHeart Radio and YouTube:
Tweet media one
0
2
2
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
The future of cancer care is at home, according to medical oncologist Dr. Roxana Dronca. Listen to her discuss Cancer Care Beyond Walls, a program to bring care and trials to people no matter where they live to improve their quality of life. 🎧.
1
2
1
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
Researchers find that the BRAF V600E mutation in a subset of colorectal cancer patients treated with immune checkpoint inhibitors is associated with a higher rate of secondary resistance, suggesting a therapeutic option that combines PD1 and CTLA4 inhibitors upfront. READ ⬇️.
@FASinicropeMD
Frank Sinicrope, MD
1 month
Implications of BRAF V600E in dMMR/MSI-H pts treated with ICIs. Prognostic impact of the BRAF V600E mutation in patients with MSI-high. @AACR @JCO_ASCO @ASCO @MayoCancerCare.
0
2
2
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
RT @oncodaily: New Episode Alert!. In the latest episode of Empowering Oncologists, Dr. Jasmine Kamboj (@JasmineKambojMD) sits down with Dr….
0
3
0
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
In some cases, patients with tumors that have favorable genetics lived even longer, with a median survival of 22 months. The study was published in The Lancet Oncology in December 2024.
Tweet card summary image
newsnetwork.mayoclinic.org
An innovative treatment approach that may offer improvement in overall survival in older patients with newly diagnosed glioblastoma.
0
0
3
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
Results showed that 56% of participants were alive after 12 months, and the median overall survival was 13.1 months. "As compared to prior phase 3 studies in an older population having a median survival of only six to nine months, these results are promising," says Dr. Vora.
1
0
3
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
Research News: Radiation oncologist Sujay Vora, M.D., studied the use of short-course hypofractionated proton beam therapy incorporating advanced imaging techniques in patients over the age of 65 with newly diagnosed #glioblastoma. #GBMDay.
1
0
3
@MayoCancerCare
Mayo Clinic Comprehensive Cancer Center
1 month
Glioblastoma is the most aggressive type of brain cancer. Globally, approximately 300,000 people are diagnosed each year. Neurosurgeon Dr. Alfredo Quinones-Hinojosa shares more about the disease and our work to study and treat it. #GBMAwarenessDay .
newsnetwork.mayoclinic.org
Dr. Alfredo Quinones-Hinojosa, a neurosurgeon at Mayo Clinic. provides a high-level look into glioblastoma.
0
1
4